Chembio Diagnostics Inc.

0.6500-0.0253-3.75%Vol 226.98K1Y Perf -78.15%
Jun 24th, 2022 16:00 DELAYED
BID0.6477 ASK0.6824
Open0.6800 Previous Close0.6753
Pre-Market- After-Market0.65
 - -  0.00 -0.35%
Target Price
9.00 
Analyst Rating
Hold 3.00
Potential %
1.28K 
Finscreener Ranking
★★+     47.95
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.23
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     39.30
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
3.39 
Earnings Rating
Buy
Market Cap19.64M 
Earnings Date
4th Aug 2022
Alpha-0.02 Standard Deviation0.29
Beta1.71 

Today's Price Range

0.65000.7000

52W Range

0.41527.34

5 Year PE Ratio Range

-9.30-6.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.33%
1 Month
-6.49%
3 Months
-26.06%
6 Months
-62.64%
1 Year
-78.15%
3 Years
-89.02%
5 Years
-89.68%
10 Years
-85.62%

TickerPriceChg.Chg.%
CEMI0.6500-0.0253-3.75
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
2.50
3.50
0.46
0.97
-12.00
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
8.30
-70.00
-64.30
-51.30
-75.28
RevenueValueIndustryS&P 500US Markets
50.37M
1.67
5.11
13.46
Earnings HistoryEstimateReportedSurprise %
Q01 2022--0.29-
Q04 2021-0.23-0.32-39.13
Q03 2021-0.21-0.23-9.52
Q02 2021-0.38-0.357.89
Q01 2021-0.30-0.2226.67
Q04 2020--0.35-
Q03 2020-0.24-0.28-16.67
Q02 2020-0.41-0.402.44
Earnings Per EndEstimateRevision %Trend
12/2020 QR-0.330.00-
3/2022 QR-0.3766.06Positive
12/2022 FY-1.36--
12/2023 FY-1.27--
Next Report Date4th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume226.98K
Shares Outstanding30.22K
Shares Float29.79M
Trades Count614
Dollar Volume151.33K
Avg. Volume155.11K
Avg. Weekly Volume73.57K
Avg. Monthly Volume189.39K
Avg. Quarterly Volume202.38K

Chembio Diagnostics Inc. (NASDAQ: CEMI) stock closed at 0.65 per share at the end of the most recent trading day (a -3.75% change compared to the prior day closing price) with a volume of 226.98K shares and market capitalization of 19.64M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 324 people. Chembio Diagnostics Inc. CEO is Richard L. Eberly.

The one-year performance of Chembio Diagnostics Inc. stock is -78.15%, while year-to-date (YTD) performance is -42.98%. CEMI stock has a five-year performance of -89.68%. Its 52-week range is between 0.415198 and 7.34, which gives CEMI stock a 52-week price range ratio of 3.39%

Chembio Diagnostics Inc. currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.76, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 649.30, a PEG ratio of 2.32, a ROA of -65.23%, a ROC of -72.17% and a ROE of -157.43%. The company’s profit margin is -75.28%, its EBITDA margin is -64.30%, and its revenue ttm is $50.37 Million , which makes it $1.67 revenue per share.

Of the last four earnings reports from Chembio Diagnostics Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Chembio Diagnostics Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Chembio Diagnostics Inc. is Hold (3), with a target price of $9, which is +1 284.62% compared to the current price. The earnings rating for Chembio Diagnostics Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chembio Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Chembio Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 23.01, ATR14 : 0.06, CCI20 : -75.63, Chaikin Money Flow : -0.16, MACD : 0.00, Money Flow Index : 37.59, ROC : -0.03, RSI : 47.02, STOCH (14,3) : 4.01, STOCH RSI : 0.05, UO : 33.15, Williams %R : -95.99), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chembio Diagnostics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Chembio Diagnostics Inc.

Chembio Diagnostics Inc is a US-based company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

CEO: Richard L. Eberly

Telephone: +1 631 924-1135

Address: 555 Wireless Boulevard, Hauppauge 11788, NY, US

Number of employees: 324

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

58%42%

Bearish Bullish

61%39%

News

Stocktwits